Lv4
570 积分 2025-01-05 加入
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
1小时前
已完结
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
17天前
已完结
Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL‐HBV and HCV studies
2个月前
已完结
Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
2个月前
已完结
Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
3个月前
已完结
Combining γ‐GT , PIVKA‐II , and AFP to predict long‐term prognosis in patients with hepatocellular carcinoma after hepatectomy
3个月前
已完结
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study
3个月前
已完结
Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
3个月前
已完结
Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab
3个月前
已完结
Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management
3个月前
已完结
皖公网安备34019202002308
